Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04467450Phase 1Unknown
Phase 1, randomised, single-blind trial of botulinum toxin type A in subacromial bursitis and subdeltoid bursitis, sponsored by Benha University. Primary endpoint: Visual Analog Scale at 10 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04467450.